Stocks To Watch KEDEM PHARMACEUTICALS INCORPORATED (OTCBB: GHLVD)
Up 5,900.01% on Monday
Kedem Pharmaceuticals Inc. (GHLVD), a development stage company, engages in acquiring and licensing healthcare related technologies for further development and re-licensing to pharmaceutical companies. The company develops a proprietary platform technology that delivers drugs through the sublingual route, to the bloodstream quickly and with minimal drug breakdown in the liver and gastro-intestinal system. Its products under development include X-Excite, a male sexual enhancement drug; Relax-B, an anti-stress drug; Nico-Z, a nicotine replacement product; V-Energy, an energy booster product; T-Slim, an appetite suppressor drug; POS001 for the growth of hair follicles; and POS002 for the treatment of cellulite. The company was formerly known as Global Health Ventures Inc. and changed its name to Kedem Pharmaceuticals Inc. in September 2011. Kedem Pharmaceuticals Inc. was founded in 2006 and is based in Vancouver, Canada.
GHLVD News:
September 16 - BetterInvesting National Convention to Host Global Health Ventures Inc., CEO to Present GHLVD Sublingual Drug Delivery System Sept. 17, 2011
11-15-11 Stocks To Watch KEDEM PHARMACEUTICALS INCORPORATED (OTCBB: GHLVD)
Global Health Ventures Inc., a specialty pharmaceutical company now doing business as Kedem Pharmaceuticals Inc. (OTCBB: GHLVD) with a focus on sublingual drug delivery, announced that CEO Dr. Hassan Salari will introduce the company to BetterInvesting National Convention participants in a corporate presentation at 1:20 p.m. on Saturday, Sept. 17. Dr. Salari will discuss the company’s Sublingual Drug Delivery System and the company’s first product in clinical trials, X-Excite, along with the company’s commercialization strategy and the management appointment of Dr. Lola Maksumova, M.D., Ph.D., as Senior Vice President and Chief Operating Officer.
Global Health Ventures has become a corporate sponsor of BetterInvesting, one of the largest non-profit retail investor organizations in the U.S. This sponsorship represents one facet of what will be Global Health Ventures’ ongoing efforts to increase its exposure to the retail investor community. Dr. Salari said: “We are pleased to present to the many investors at the BetterInvesting National Convention and are excited to have a platform for review by the investment community. The corporate presentation allows us to educate potential shareholders in more detail about our goals to commercialize our sublingual drug delivery system.”
If you find our information valuable, Subscribe to Strategic Stocks and Penny Stocks RSS Feed by e-mail, to Receive our Updates INSTANTLY, and share this post/page with your friends and followers with use of the Social Buttons.
Like all investment strategies, trading in stocks involves risk and volatility. Past performance is not an indication of future results. Actual results will be based on a consumer’s individual purchase and sale decisions.
Please read our Disclaimer regards to GHLVD or any company reviewed or blogged about at Strategic Penny Stocks.
